Yan Gao

Summary

Country: China

Publications

  1. ncbi request reprint Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study
    Ge Heng Yuan
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Chin Med J (Engl) 125:2677-81. 2012
  2. doi request reprint Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus
    Xiao Hui Guo
    Peking University First Hospital, Beijing, China
    Curr Med Res Opin 29:169-74. 2013
  3. ncbi request reprint [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics]
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Zhonghua Yi Xue Za Zhi 89:1960-3. 2009
  4. ncbi request reprint [A comparison of efficacy and tolerance of nateglinide and acarbose monotherapy in type 2 diabetes mellitus]
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 48:304-7. 2009
  5. doi request reprint Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing, China
    Diabetes Res Clin Pract 83:69-76. 2009
  6. ncbi request reprint Effects of timely insulin treatment on protection of beta cells in a rat model of type 2 diabetes mellitus
    Ying Sheng Zhou
    Department of Endocrinology, First Hospital of Peking University, Beijing 100034, China
    Chin Med J (Engl) 117:1523-9. 2004
  7. ncbi request reprint [A randomized, double blind, placebo-controlled, parallel and multicenter study to evaluate the safety and efficacy of pioglitazone with sulphonylurea in type 2 diabetic patients]
    Zhao Hui Lu
    Department of Endocrinology, PLA General Hospital, Beijing, China
    Zhonghua Nei Ke Za Zhi 50:826-30. 2011
  8. ncbi request reprint Switching from human insulin to biphasic insulin aspart 30 treatment gets more patients with type 2 diabetes to reach target glycosylated hemoglobin < 7%: the results from the China cohort of the PRESENT study
    Yan Gao
    Department of Endocrinology, Peiking University First Hospital, Beijing 100034, China
    Chin Med J (Engl) 123:1107-111. 2010
  9. ncbi request reprint Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Chin Med J (Engl) 123:3184-92. 2010
  10. ncbi request reprint [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus]
    Guang Wei Li
    Department of Endocrinology, China Japan Friendship Hospital, Beijing 100029, China
    Zhonghua Nei Ke Za Zhi 43:510-4. 2004

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study
    Ge Heng Yuan
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Chin Med J (Engl) 125:2677-81. 2012
    ..Incretin-based therapies provide additional options for treating type 2 diabetes. We aimed to evaluate the efficacy and tolerability of exenatide monotherapy in obese patients with type 2 diabetes...
  2. doi request reprint Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus
    Xiao Hui Guo
    Peking University First Hospital, Beijing, China
    Curr Med Res Opin 29:169-74. 2013
    ..To investigate the efficacy and safety of glimepiride as initial mono-therapy in type 2 diabetes patients in China...
  3. ncbi request reprint [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics]
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Zhonghua Yi Xue Za Zhi 89:1960-3. 2009
    ..To compare the efficacy and safety of insulin aspart (IAsp) and human insulin (HI) when applied as meal-time insulin with neutral protamine Hagedorn insulin (NPH) at bedtime in diabetics...
  4. ncbi request reprint [A comparison of efficacy and tolerance of nateglinide and acarbose monotherapy in type 2 diabetes mellitus]
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 48:304-7. 2009
    ..To compare the efficacy and tolerability of nateglinide with those of acarbose in Chinese type 2 diabetes mellitus (T2DM) patients...
  5. doi request reprint Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing, China
    Diabetes Res Clin Pract 83:69-76. 2009
    ..To evaluate the efficacy of exenatide in Asian patients with type 2 diabetes (T2D) inadequately controlled with oral agents...
  6. ncbi request reprint Effects of timely insulin treatment on protection of beta cells in a rat model of type 2 diabetes mellitus
    Ying Sheng Zhou
    Department of Endocrinology, First Hospital of Peking University, Beijing 100034, China
    Chin Med J (Engl) 117:1523-9. 2004
    ..The purpose of this study was to investigate the effects of early insulin treatment on insulin mRNA expression and morphological alterations of beta cells in a Sprague Dawley (SD) rat model of type 2 diabetes...
  7. ncbi request reprint [A randomized, double blind, placebo-controlled, parallel and multicenter study to evaluate the safety and efficacy of pioglitazone with sulphonylurea in type 2 diabetic patients]
    Zhao Hui Lu
    Department of Endocrinology, PLA General Hospital, Beijing, China
    Zhonghua Nei Ke Za Zhi 50:826-30. 2011
    ..To evaluate the safety and efficacy of 30 mg pioglitazone hydrochloride combined with sulphonylurea in the treatment of type 2 diabetic patients...
  8. ncbi request reprint Switching from human insulin to biphasic insulin aspart 30 treatment gets more patients with type 2 diabetes to reach target glycosylated hemoglobin < 7%: the results from the China cohort of the PRESENT study
    Yan Gao
    Department of Endocrinology, Peiking University First Hospital, Beijing 100034, China
    Chin Med J (Engl) 123:1107-111. 2010
    ..We use data from a Chinese cohort of the PRESENT study...
  9. ncbi request reprint Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Chin Med J (Engl) 123:3184-92. 2010
    ..This study assessed the efficacy and safety of duloxetine in Chinese patients with diabetic peripheral neuropathic pain...
  10. ncbi request reprint [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus]
    Guang Wei Li
    Department of Endocrinology, China Japan Friendship Hospital, Beijing 100029, China
    Zhonghua Nei Ke Za Zhi 43:510-4. 2004
    ..To evaluate the efficacy and safety profile of a slow-released-gliclazide (Diamicron MR) in type 2 diabetes patients...
  11. pmc A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
    Xiao wei Ma
    Department of Endocrinology, Peking University First Hospital, No 7 of Xishiku Street, Xicheng District, Beijing 100034, China
    J Geriatr Cardiol 9:228-36. 2012
    ..To evaluate the plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus (T2DM) and arteriosclerosis obliteran (ASO) when treated with Probucol plus Cilostazol in combination and individually...
  12. ncbi request reprint [A clinical pathological study of thyroid nodules detected by physical examinations]
    Song Dong
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Zhonghua Nei Ke Za Zhi 47:189-92. 2008
    ....
  13. ncbi request reprint [Epitope mapping of myeloperoxidase antibodies in propylthiouracil-induced vasculitis and microscopic polyangiitis]
    Hua Ye
    Department of Endocrinology, The First Hospital, Peking University, Beijing 100034, China
    Zhonghua Nei Ke Za Zhi 43:915-9. 2004
    ..To compare the epitopes of antibodies for myeloperoxidase (MPO) in the serum from patients with propylthiouracil (PTU) induced vasculitis and microscopic polyangiitis (MPA)...
  14. ncbi request reprint [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study]
    Changyu Pan
    Department of Endocrinology, General Hospital of PLA, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 41:388-92. 2002
    ..To evaluate the efficacy and safety of pioglitazone hydrochloride 30 mg/day with sulphonylureas and metfomin in the treatment of patients with type 2 diabetes mellitus...